Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Generic for dutasteride?

See the DrugPatentWatch profile for dutasteride

The generic version of dutasteride is available and is also called dutasteride [1].

What is dutasteride used for?


Dutasteride is a medication used to treat symptomatic benign prostatic hyperplasia (BPH), also known as an enlarged prostate, in men [1]. It can also be used to reduce the risk of urinary retention and the need for surgery in men with moderate to severe BPH [1]. Additionally, it is used in combination with the medication tamsulosin to treat men with moderate to severe BPH [1].

How does dutasteride work?


Dutasteride belongs to a class of drugs called 5-alpha reductase inhibitors [1]. It works by reducing the production of a hormone called dihydrotestosterone (DHT) [1]. DHT is responsible for the growth of the prostate gland. By lowering DHT levels, dutasteride helps to shrink the prostate gland and improve urinary symptoms associated with BPH [1].

When does dutasteride's patent expire?


Patent expiration dates for medications can be complex and involve multiple patents. For dutasteride, the primary patent was expected to expire around November 2024 [2]. However, various secondary patents and exclusivities can extend market protection. DrugPatentWatch.com tracks these details for pharmaceutical products [2].

Are there any generic alternatives to dutasteride?


The generic version of dutasteride is available [1]. In cases of BPH treatment, other classes of drugs may be considered as alternatives or in combination therapy. These can include alpha-blockers (like tamsulosin, alfuzosin, or silodosin), which relax the muscles in the prostate and bladder neck to improve urine flow, or other medications that reduce prostate size [1].

What are the side effects of dutasteride?


Common side effects of dutasteride can include decreased libido, erectile dysfunction, and ejaculation disorders [1]. Less common side effects can include breast tenderness and enlargement, and rash [1]. It is important for patients to discuss any potential side effects with their healthcare provider.

Can dutasteride be used by women or children?


Dutasteride is not indicated for use in women or children. It can cause birth defects in male fetuses, and women who are pregnant or may become pregnant should not handle the medication [1].

What is the difference between dutasteride and finasteride?


Both dutasteride and finasteride are 5-alpha reductase inhibitors used to treat BPH and hair loss (in finasteride's case) [1]. However, dutasteride inhibits two types of the 5-alpha reductase enzyme (Type I and Type II), while finasteride primarily inhibits Type II [1]. This difference means dutasteride reduces DHT levels more significantly than finasteride [1].

What is the typical cost of generic dutasteride?


The cost of generic dutasteride can vary depending on the pharmacy, insurance coverage, and dosage [3]. It is generally less expensive than the brand-name version, Avodart [3]. Patients are advised to compare prices at different pharmacies and inquire about prescription discount programs.

What clinical data supports the use of dutasteride?


Clinical trials have demonstrated the efficacy of dutasteride in reducing prostate volume and improving urinary symptoms in men with BPH [1]. Studies have also shown its effectiveness in reducing the risk of acute urinary retention and the need for surgical intervention in men with moderate to severe BPH [1].

Who manufactures dutasteride and its generic versions?


The brand-name version of dutasteride, Avodart, was originally developed by GlaxoSmithKline [4]. Following patent expirations, numerous pharmaceutical companies have begun manufacturing and marketing generic versions of dutasteride [1].

---
Sources:

[1] https://www.drugpatentwatch.com/
[2] https://www.drugpatentwatch.com/dutasteride-patent-information
[3] https://www.drugpatentwatch.com/dutasteride-price
[4] https://www.drugpatentwatch.com/avodart-patent-information



Other Questions About Dutasteride :

dutasteride 0.5 mg price Dutasteride patent? Dutasteride paten? Dutasteride generic cost? Dutasteride trade name? Why is dutasteride so expensive? Dutasteride tablets 0 5 mg uses?

AI-Drug Label Prescribing Information Alignment Report

63
63%
Grade C

Partial

Partially Aligned

Patient Risk: Medium

Summary

Most on-label clinical indication and safety points are supported by the provided label excerpts, but multiple claims are not supported because they concern patent/market status or specific comparative assertions that are absent from the supplied prescribing information; several additional assertions use qualifiers (e.g., “moderate to severe”) and frequency framing that are not verifiably present in the excerpts.


Category Scores

Indication
85
Good
Dosage
0
Partial
Contraindications
95
Excellent
Warnings
92
Excellent
SpecificPopulations
90
Excellent
AdverseReactions
78
Good

Accurate Statements

Dutasteride is used to treat symptomatic BPH in men.
Supported by 14.1 (Monotherapy) and 1.2 (Combination with alpha-adrenergic antagonist) excerpts.
Dutasteride reduces the risk of acute urinary retention (AUR) in men with BPH.
Supported by 14.1 Monotherapy excerpt: reduce the risk of acute urinary retention (AUR).
Dutasteride reduces the risk of the need for BPH-related surgery.
Supported by 14.1 Monotherapy excerpt: reduce the risk of the need for BPH-related surgery.
Dutasteride in combination with tamsulosin is indicated for symptomatic BPH in men with an enlarged prostate.
Supported by 1.2 Combination with Alpha-adrenergic Antagonist and 14.2 CombAT excerpts.
Dutasteride is a 5-alpha reductase inhibitor.
Supported by 8.1 Pregnancy excerpt: "AVODART is a 5 alpha‑reductase inhibitor".
Dutasteride inhibits conversion of testosterone to DHT and reduces DHT.
Supported by 12.1 Mechanism of Action and 12.2 Pharmacodynamics excerpts.
DHT is primarily responsible for the initial development and subsequent enlargement of the prostate gland.
Supported by 12.1 Mechanism of Action excerpt.
Common adverse reactions include decreased libido and ejaculation disorders (and breast disorders including enlargement/tenderness).
Supported by 6.1 Clinical Trials Experience excerpt: most common adverse reactions include decreased libido, breast disorders (including breast enlargement and tenderness), and ejaculation disorders.
Dutasteride is contraindicated in pregnancy (women who are pregnant).
Supported by 4 Contraindications and 8.1 Pregnancy excerpts.
Women who are pregnant or may be pregnant should not handle AVODART capsules.
Supported by 5.4 Transdermal Exposure excerpt.
AVODART is not indicated for women or pediatric patients.
Supported by 8.1 (not indicated for use in women) and 8.4 (not indicated for use in pediatric patients).

Unsupported Statements

A generic version of dutasteride is available.
Not addressed in the supplied FDA-approved prescribing information excerpts.
The primary patent for dutasteride was expected to expire around November 2024.
Patent timing is not present in the supplied label excerpts.
Patent expiration details for dutasteride can involve multiple patents and secondary patents and exclusivities can extend market protection.
Market/patent/exclusivity details are not present in the supplied label excerpts.
Dutasteride reduces DHT levels more significantly than finasteride.
No comparative finasteride-vs-dutasteride DHT magnitude claim is present in the supplied label excerpts.
Less common side effects of dutasteride can include rash.
No rash occurrence/frequency claim is supported by the supplied label excerpts.
The brand-name version of dutasteride (Avodart) was originally developed by GlaxoSmithKline.
Product-development/manufacturer history is not present in the supplied label excerpts.
Following patent expirations, numerous pharmaceutical companies have begun manufacturing and marketing generic versions of dutasteride.
Manufacturing/marketing statements are not present in the supplied label excerpts.

Contradictions

Low

AI Statement
None of the provided AI claims directly contradict the supplied label excerpts.

Label Reference


Important Omissions

Dosage and administration details (dose, regimen, administration instructions) are not evaluated because no dosage/administration claims were provided in the extracted claims.
Importance: Moderate

Safety Assessment

Potential Patient Risk: Medium
Some safety-related items (pregnancy handling/contraindication and fetal risk) are supported, but unsupported market/patent claims and an unsupported comparative pharmacodynamic claim (dutasteride vs finasteride) could misinform decision-making if treated as labeling facts. Frequency/qualifier framing (e.g., “moderate to severe” BPH; “less common” rash) is not supported by the supplied excerpts.

Regulatory Assessment

On Label No
Off-label Discussion No
Promotes Unapproved Use No
Hallucination Risk Medium

Recommendation

Partially Aligned

Primary Issue
Multiple claims are not supported by the supplied prescribing information (patent/generic/manufacturing history and a comparative efficacy/pharmacodynamic statement), and some claims use qualifiers/frequency language not verifiable in the provided excerpts.

Suggested Improvement
Restrict claims to those explicitly present in the provided label sections (especially indication endpoints and safety statements), remove patent/market/manufacturer assertions, and avoid unsupported comparative or frequency/severity qualifier phrasing unless the exact label wording is provided.

Drug Brand Mention Assessment

Branding Score
63
Visibility
66
Mentioned
Ranking
#1
Sentiment
55
Recommendation Status
mentioned only
Brand Perception
Best Known For

It works by reducing the production of a hormone called dihydrotestosterone (DHT).


Core Claims
  • The generic version of dutasteride is available and is also called dutasteride.
  • Dutasteride is used to treat symptomatic benign prostatic hyperplasia (BPH).
  • It can reduce the risk of urinary retention and the need for surgery in men with moderate to severe BPH.
  • It belongs to a class of drugs called 5-alpha reductase inhibitors.
Differentiators
  • Dutasteride inhibits two types of the 5-alpha reductase enzyme (Type I and Type II).
  • The difference is described as dutasteride reducing DHT levels more significantly than finasteride.

Pricing Perception: Mid Range
Competitors Mentioned
Company Visibility Sentiment Rank Recommended
tamsulosin 20%
50 #3 No
alfuzosin 20%
50 #4 No
silodosin 20%
50 #5 No
finasteride 44%
50 #7 No
Avodart 44%
55 #8 No
GlaxoSmithKline 10%
50 #9 No